Compare Adaptive Biotechnologies Corp (ADPT) vs ARK Next Generation Internet ETF (ARKW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs ARK Next Generation Internet ETF — how do they compare? Adaptive Biotechnologies Corp trades at $20.12 (market cap $3.33B), while ARK Next Generation Internet ETF trades at $144.89. The key difference: Adaptive Biotechnologies Corp is trading nearer its 52-week high, ARK Next Generation Internet ETF nearer its low. Which is the better fit depends on your goals.
| ADPT | ARKW | |
|---|---|---|
Market Cap | $3.33B | — |
Sector | Health | Sector/Thematic |
52-Week High | $22.37 | $182.20 |
52-Week Low | $10.24 | $114.45 |
Enterprise Value | $3.19B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $20.82, down 1.75% today, with a bullish technical signal from moving averages and a consensus analyst price target of $20.40. The company announced a strategic separation of its MRD and Immune Medicine businesses in June 2026, alongside a $300 million convertible notes offering to enhance financial flexibility. Revenue grew to $277 million in 2025, though net losses persist at -$59.50 million, with improving margins and cash flow trends showing net positive cash generation of $22.37 million.
Outlook remains cautiously optimistic as the business split aims to unlock value, but execution risks and sustained profitability challenges pose headwinds. Analysts are predominantly bullish (64.71% buy ratings), citing growth in the clonoSEQ MRD segment, yet the stock faces volatility from high valuation multiples and insider selling activity.
ARKW is trading at $150.00, up 3.32% with strong technical momentum showing bullish moving averages and key indicators like ADX signaling upward trend strength. The stock faces resistance near $151-152 with support at $144-142. Recent news highlights ARK Invest's Cathie Wood sharing investments in Magnificent Seven stocks with Bill Ackman, indicating institutional confidence in growth-oriented technology holdings.
The ETF's exposure to innovative technology companies presents growth potential amid AI and digital transformation trends. Key risks include concentration in volatile tech sectors and market sensitivity to interest rate changes. Current technical strength suggests near-term upside potential if resistance levels are breached.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About ARK Next Generation Internet ETF
ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.
Read more on ARKW →
